The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study
Official Title: A Phase II Study Using 18F-FDOPA Positron Emission Tomography Imaging for Neurosurgery and Assessment of Surgical Resection
Study ID: NCT01248754
Brief Summary: The 18F-FDOPA PET tracer is an amino acid analogue that can be used to visualize high-grade glioma not clearly identified on diagnostic MRI. Use of 18F-FDOPA PET will permit neurosurgeons to achieve a complete resection more frequently.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Lions Gate Hospital, North Vancouver, British Columbia, Canada
Vancouver General Hospital, Vancouver, British Columbia, Canada
BC Cancer Agency, Vancouver, British Columbia, Canada
Name: Alan Nichol, MD
Affiliation: British Columbia Cancer Agency
Role: PRINCIPAL_INVESTIGATOR